Systemic therapy for advanced basal cell carcinoma

Lancet Oncol. 2015 Jun;16(6):608-10. doi: 10.1016/S1470-2045(15)70233-0. Epub 2015 May 13.

Authors

Catriona M Maybury¹, Emma E Craythorne², Teresa Guerrero Urbano³, Raj Mallipeddi²

Affiliations

¹ St John's Institute of Dermatology, Guys and St Thomas' NHS Foundation Trust, London, UK; St John's Institute, Division of Genetics and Molecular Medicine, King's College London, London, UK. Electronic address: Catriona.maybury@kcl.ac.uk.
² St John's Institute of Dermatology, Guys and St Thomas' NHS Foundation Trust, London, UK.
³ Oncology Department, Guys and St Thomas' NHS Foundation Trust, London, UK.

PMID: 25981816
DOI: 10.1016/S1470-2045(15)70233-0

No abstract available

Publication types

Comment

MeSH terms

Anilides / administration & dosage*
Biphenyl Compounds / administration & dosage*
Carcinoma, Basal Cell / drug therapy*
Drug-Related Side Effects and Adverse Reactions / pathology*
Female
Humans
Male
Neoplasm Recurrence, Local / drug therapy*
Pyridines / administration & dosage*
Skin Neoplasms / drug therapy*

Substances

Anilides
Biphenyl Compounds
Pyridines